HIV drug response web service

Issue: BCMJ, vol. 53, No. 2, March 2011, Page 93 News

Two multinational clinical studies indicate that the HIV Resistance Response Database Initiative (RDI’s) system for predicting how HIV and AIDS patients will respond to different drugs could be a useful tool with potential clinical and economic benefits. The studies, published in the January issue of AIDS Patient Care and STDs, involved physicians in the US, Canada, and Italy who used the system to help them select the optimum combination of HIV drugs for pa­tients whose therapy was failing. 

The HIV Treatment Response Prediction System (HIV-TRePS) uses computer models that have been train­ed with data from thousands of pa­tients around the world. 

In these studies physicians entered their patient’s data and their selection of the next combination of HIV drugs via the In­ternet. A prototype version of HIV-TRePS predicted how the patient would respond to hundreds of alternative combinations of HIV drugs. Within seconds the physician received a report listing the drug combinations that the models predicted were most likely to work. The phy­sicians then recorded their final treatment decision and completed an online evaluation.

Use of the system was associated with a change of treatment decision in one-third of cases to combinations with fewer drugs overall, which were predicted to result in better virological responses. Evaluations indicated that the physicians found the system to be easy and useful. Based on these findings, use of the system could potentially improve patient outcomes and reduce the overall number and cost of drugs used. An improved version of HIV-TRePS is now available free at The publication can be viewed at

. HIV drug response web service. BCMJ, Vol. 53, No. 2, March, 2011, Page(s) 93 - News.

Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.

For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit

BCMJ Guidelines for Authors

Leave a Reply